BATS | ETF
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 10.95% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 8.41% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 7.45% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 6.06% |
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 5.70% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.91% |
| PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 4.24% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 4.12% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 4.04% |
| CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 3.87% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 3.82% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 3.81% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.38% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 3.24% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 2.93% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.48% |
| ABSI | Absci Corp | Healthcare | Biotechnology | 2.38% |
| ARCT | Arcturus Therapeutics Holdings Inc | Healthcare | Biotechnology | 2.10% |
| NRIX | Nurix Therapeutics Inc | Healthcare | Biotechnology | 1.84% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.58% |